TRIB News and Press, Trinity Biotech plc From 04/27/23

DUBLIN, Ireland, April 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that it has closed the recently announced sale ...

2023-04-24 18:36:40 ET Trinity Biotech ( NASDAQ: TRIB ) on Monday said it had got a notice that it was not in compliance with a Nasdaq listing rule on minimum stock bid price. The company got the non-compliance notice as the minimum bid price of its American depositary sha...

DUBLIN, Ireland, April 24, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on April 19, 2023 the Company received not...

DUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced it has entered into an agreement to sell its Fi...

2023-03-23 15:47:05 ET Trinity Biotech plc (TRIB) Q4 2022 Earnings Conference Call March 23, 2023 10:00 A.M. ET Company Participants Joe Diaz - Lytham Partners, Investor Relations Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer ...

2023-03-23 09:24:04 ET Trinity Biotech press release ( NASDAQ: TRIB ): Q4 EPS of -$0.27 may not be comparable to consensus of -$0.06. Revenue of $18M (-7.8% Y/Y) in-line. For further details see: Trinity BiotechEPS of -$0.27, revenue of $18M in-line

DUBLIN, Ireland, March 23, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2022 and fiscal year 2022. ...

2023-03-22 12:24:09 ET Trinity Biotech ( NASDAQ: TRIB ) is scheduled to announce Q4 earnings results on Thursday, March 23rd, before market open. The consensus EPS Estimate is -$0.06 (-Infinity% Y/Y) and the consensus Revenue Estimate is $18M (-7.8% Y/Y). Over the last...

DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today welcomed the announcement by the Kenyan Ministry of Health...

DUBLIN, Ireland, March 16, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2022 on Thursday, March 2...